MetLife Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Sell |
74,301
-9,507
| -11% | -$80.5K | ﹤0.01% | 1571 |
|
|
2025
Q1 | $674K | Sell |
83,808
-1,872
| -2% | -$15.1K | ﹤0.01% | 1556 |
|
|
2024
Q4 | $769K | Buy |
85,680
+2,918
| +4% | +$26.2K | ﹤0.01% | 1557 |
|
|
2024
Q3 | $607K | Hold |
82,762
| – | – | ﹤0.01% | 1671 |
|
|
2024
Q2 | $473K | Buy |
82,762
+11,561
| +16% | +$66K | ﹤0.01% | 1745 |
|
|
2024
Q1 | $357K | Hold |
71,201
| – | – | ﹤0.01% | 1863 |
|
|
2023
Q4 | $640K | Hold |
71,201
| – | – | ﹤0.01% | 1544 |
|
|
2023
Q3 | $553K | Hold |
71,201
| – | – | ﹤0.01% | 1567 |
|
|
2023
Q2 | $689K | Hold |
71,201
| – | – | 0.01% | 1487 |
|
|
2023
Q1 | $780K | Hold |
71,201
| – | – | 0.01% | 1366 |
|
|
2022
Q4 | $308K | Hold |
71,201
| – | – | ﹤0.01% | 1967 |
|
|
2022
Q3 | $535K | Hold |
71,201
| – | – | ﹤0.01% | 1590 |
|
|
2022
Q2 | $716K | Buy |
+71,201
| New | +$716K | 0.01% | 1417 |
|